NDC11 11788011801
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 11788-0118-01 | 11788-0118 |
| 11788-0118-1 | 11788-0118 |
| 11788-118-01 | 11788-118 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glipizide | GLIPIZIDE | AiPing Pharmaceutical, Inc. | ccfa5a38-3f90-48f4-b226-51e91497c06f | 2026-10-09 | Warnings, Adverse reactions | 11788-118 |
| Glipizide | GLIPIZIDE | AiPing Pharmaceutical, Inc. | 2110a7ca-3c1f-4db4-9211-65546b74533c | 2026-10-09 | Warnings, Adverse reactions | 11788-118-01 11788-118 11788011801 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.